(19)
(11) EP 2 533 783 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
16.12.2015 Bulletin 2015/51

(45) Mention of the grant of the patent:
04.11.2015 Bulletin 2015/45

(21) Application number: 11733353.4

(22) Date of filing: 13.01.2011
(51) International Patent Classification (IPC): 
A61K 31/497(2006.01)
C07D 417/14(2006.01)
C07D 413/14(2006.01)
 C07D 413/12(2006.01)
C07D 271/06(2006.01)
A61P 37/00(2006.01)
(86) International application number:
PCT/US2011/021089
(87) International publication number:
WO 2011/088181 (21.07.2011 Gazette 2011/29)

(54)

COMPOUNDS AND METHODS for the inhibition of HDAC

VERBINDUNGEN UND VERFAHREN zur Inhibierung von HDAC

COMPOSÉS ET PROCÉDÉS pour l' inhibition d' HDAC

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 13.01.2010 US 294575 P

(43) Date of publication of application:
19.12.2012 Bulletin 2012/51

(73) Proprietor: Tempero Pharmaceuticals, Inc.
Wilmington, DE 19808 (US)

(72) Inventors:
  • BALOGLU, Erkan
    Cambridge, MA 02139 (US)
  • GHOSH, Shomir
    Cambridge, MA 02139 (US)
  • LOBERA, Mercedes
    Cambridge, MA 02139 (US)
  • SCHMIDT, Darby
    Cambridge, MA 02139 (US)

(74) Representative: Priestley, Ruth Elizabeth et al
GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)


(56) References cited: : 
WO-A1-01/18045
 US-A1- 2009 048 228
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).